DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ slipped 2.30% to $600.66 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.26% to 7,599.96 and the Dow Jones Industrial Average rising 0.09% to 51,078.88.
This was the stock's seventh consecutive day of losses.
Regeneron Pharmaceuticals Inc. closed 26.85% short of its 52-week high of $821.11, which the company reached on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. $(AMGN)$ fell 2.27% to $329.13, Moderna Inc. (MRNA) fell 2.39% to $46.06, and Gilead Sciences Inc. (GILD) fell 2.48% to $131.10.
Trading volume (1.1 M) eclipsed its 50-day average volume of 877,224.
Data source: Dow Jones Market Data, FactSet. Data compiled June 1, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 01, 2026 16:45 ET (20:45 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.